http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008116316-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate | 2006-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2008116316-A |
| titleOfInvention | NEW COMPOSITION |
| abstract | 1. A pharmaceutical composition, tablet or tablet obtained by direct compression, containing from 50 to 98 wt.%, From 60 to 98 wt.%, From 70 to 98 wt.% Or from 80 to 98 wt.% Of the active ingredients, calculated on the mass of dry active ingredients, the active ingredients include vildagliptin and metformin, or in each case their pharmaceutically acceptable salts. ! 2. The composition or tablet according to claim 1, containing at least one pharmaceutically acceptable excipient. ! 3. The composition or tablet according to claim 1, containing metformin in the form of granules. ! 4. The composition or tablet according to claim 3, containing metformin in the form of granules that contain at least one pharmaceutically acceptable excipient. ! 5. The composition or tablet according to claim 3, containing metformin in the form of granules that contain a binding agent. ! 6. The composition or tablet according to claim 3, containing metformin in the form of granules that contain from 1 to 25% of a binding agent. ! 7. The composition or tablet according to claim 1, containing! 1) from 1 to 25 wt.%, From 1 to 20 wt.% Or from 1 to 12 wt.% Based on the weight of the dry pharmaceutically acceptable binding agent,! 2) from 2.9 to 11 wt.% Or from 6.5 to 9.5 wt.% Based on the weight of the dry pharmaceutically acceptable binding agent, or! 3) from 7.5 to 17.5 wt.% Or from 12.5 to 17.5 wt.% Based on the weight of the dry pharmaceutically acceptable binding agent. ! 8. The tablet according to claim 1, obtained by direct compression of metformin granules in combination with vildagliptin and optionally at least one pharmaceutically acceptable excipient. ! 9. A pharmaceutical composition or tablet, which as active ingredients includes:! 1) from 1.5 to 35% of a DPP-IV inhibitor or its pharmaceutically acceptable salt,! 2 |
| priorityDate | 2005-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.